SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]:
SEC Accession No. 0001062993-20-000272
Filing Date
2020-01-23
Accepted
2020-01-22 18:25:15
Documents
3
Effectiveness Date
2020-01-23

Document Format Files

Seq Description Document Type Size
1 SUPPL formsuppl.htm SUPPL 408119
2 GRAPHIC formf10x3x1.jpg GRAPHIC 3260
3 GRAPHIC formsupplx001.jpg GRAPHIC 7180
  Complete submission text file 0001062993-20-000272.txt   423762
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: SUPPL | Act: 98 | File No.: 333-222085 | Film No.: 20539893
SIC: 2834 Pharmaceutical Preparations